Travere Therapeutics, Inc. Stock Performance

Open $53.10	Prev. Close $53.47	Circuit Range N/A
Day Range $51.49 - $53.10	Year Range $22.59 - $68.55	Volume 90,764
Average Traded $52.11

Travere Therapeutics, Inc. Share Price Today

As of 9 October 2026, Travere Therapeutics, Inc.'s share price is $52.05. The stock opened at $53.10, compared to its previous close of $53.47. During today's trading session, Travere Therapeutics, Inc.'s share price traded between $51.49 and $53.10, with an average price of $52.30. Over the past 52 weeks, the stock has recorded a high of $68.55 and a low of $22.59. In terms of performance, Travere Therapeutics, Inc.'s share price has risen by 23.59% over the last six months and is up 47.92% on a year-on-year basis.

Travere Therapeutics, Inc. Share Price Chart

$51.49$53.10

Travere Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $4.64B	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-0.46	Revenue (TTM) $490.73B	Return On Equity (TTM) -177.24%
Profit Margin -5.21%	Debt to Equity 24.58	Quarterly Earnings Growth YoY -235.36%

Travere Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$164.86	$129.69	$127.20	$169.58
Net Profit	$25.71	$2.73	-$37.10	-$34.80
Net Profit Margin	15.60%	2.11%	-29.17%	-20.52%
Income Change	N/A	-89.38%	-1458.97%	6.20%

Travere Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$109.46	$145.24	$233.18	$490.73
Net Profit	-$278.48	-$111.40	-$321.55	-$25.55
Net Profit Margin	-254.41%	-76.70%	-137.90%	-5.21%
Income Change	N/A	60.00%	-188.64%	92.05%

About Travere Therapeutics, Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Travere Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$58.65	$52.05	-11.73%
Sep 2026	$65.88	$58.97	-12.61%
Aug 2026	$53.63	$67.48	+20.67%
Jul 2026	$57.10	$55.92	-1.51%
Jun 2026	$46.74	$56.78	+20.32%
May 2026	$42.31	$47.19	+12.06%
Apr 2026	$30.19	$42.11	+41.78%
Mar 2026	$29.93	$29.70	-0.47%
Feb 2026	$31.32	$29.84	-4.05%
Jan 2026	$38.62	$31.10	-18.63%
Dec 2025	$34.88	$38.22	+7.83%
Nov 2025	$34.83	$35.45	+0.74%

TVTX Share Price FAQs

What is Travere Therapeutics, Inc. share price today?

Travere Therapeutics, Inc. share price today is $52.05 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Travere Therapeutics, Inc. stock?

The 52 week high of Travere Therapeutics, Inc. stock is $68.55, while the 52 week low is $22.59 as of 9 Oct '26.

What is TVTX's market capitalisation today?

TVTX market capitalisation is $4.64B as of October 9, 2026, at 9:54 am IST.

What is TVTX's net income for the last quarter?

TVTX's net income for the last quarter is -34.80B USD.

What is the 5 year returns of TVTX?

The 5 year returns of TVTX is 80.65% as on 9 Oct '26.

What is the high & low stock price of TVTX today?

TVTX stock price hit a high of $53.10 and low of $51.49 as of 9 Oct '26.

Can I buy TVTX shares in India?

Yes. You can buy TVTX in India by opening an international trading account.